Related Experiment Video

Updated: Jun 28, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

956

Ferroptosis in liver cancer: a key role of post-translational modifications

Ying Xu1, Zhiyao Xing1, Ruaa Abdalla Ibrahim Suliman1

  • 1School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.

Frontiers in Immunology
|April 23, 2024
PubMed

Insights

Ferroptosis, a cell death pathway, is key to inhibiting liver tumors. Understanding post-translational modifications (PTMs) in ferroptosis resistance is crucial for developing effective hepatocellular carcinoma (HCC) treatments.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Ferroptosis is an iron-dependent regulated cell death pathway.
  • Over-production of reactive oxygen species (ROS) induces ferroptosis.
  • Ferroptosis manipulation is a promising strategy for liver tumor growth inhibition.

Purpose of the Study:

  • To review the roles of post-translational modifications (PTMs) in ferroptosis.
  • To explore PTMs' impact on ferroptosis resistance in hepatocellular carcinoma (HCC).
  • To identify PTMs as potential therapeutic targets for HCC treatment.

Main Methods:

  • Literature review focusing on PTMs and ferroptosis.
  • Analysis of PTMs' regulatory roles in ferroptosis-related proteins.
  • Investigation of PTMs' involvement in ferroptosis resistance mechanisms.

Main Results:

  • PTMs critically regulate protein function, stability, and cellular activities.
  • PTMs are involved in various programmed cell death pathways, including ferroptosis.
  • Key PTMs regulators are identified as potential therapeutic targets.

Conclusions:

  • PTMs play a significant role in regulating ferroptosis.
  • Understanding PTMs in ferroptosis resistance is vital for HCC treatment strategies.
  • Targeting PTMs offers a promising avenue for overcoming ferroptosis resistance in HCC.
Keywords:
PTMsHCCdrug resistanceferroptosisimmunotherapy

More Related Videos

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.1K
Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins08:12

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins

Published on: January 8, 2018

11.3K

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
5.7K
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K